Silence Therapeutics (SLN) Institutional Ownership → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free SLN Stock Alerts $22.95 +0.35 (+1.55%) (As of 05/9/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Silence Therapeutics (NASDAQ:SLN)CurrentInstitutional OwnershipPercentage98.73%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$34.21MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$372.00K Get SLN Insider Trade Alerts Want to know when executives and insiders are buying or selling Silence Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SLN Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Silence Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/7/2024 SG Americas Securities LLC7,000$151K0.0%+10.5%0.023% 4/22/2024 Vivo Capital LLC1,105,454$23.88M1.9%+116.7%3.694% 2/15/2024Parkman Healthcare Partners LLC232,942$4.05M0.6%+20.8%0.778% 2/15/2024Cantor Fitzgerald L. P.146,777$2.55M0.5%-12.7%0.490% 2/7/2024 Vivo Capital LLC510,204$8.86M0.7%N/A1.705% 1/12/2024 SG Americas Securities LLC6,333$110K0.0%N/A0.021% Get the Latest News and Ratings for SLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Silence Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2023Lynx1 Capital Management LP235,787$2.32M1.5%N/A0.788% 8/15/2023Cantor Fitzgerald L. P.293,893$1.62M0.0%+1.6%0.982% 8/14/2023Lombard Odier Asset Management Europe Ltd3,415,360$18.78M0.9%+3.7%11.411% 8/14/2023Lombard Odier Asset Management USA Corp4,120,416$18.67M0.4%+4.1%13.767% 8/11/2023M28 Capital Management LP363,800$2.00M2.6%+149.3%1.216% 8/11/2023Artal Group S.A.1,700,000$9.35M0.3%+236.6%5.680% 2/14/2023Lombard Odier Asset Management Europe Ltd3,218,200$49.08M2.0%0.0%8.967% 2/10/2023M28 Capital Management LP145,900$2.23M2.1%N/A0.407% 2/2/2023 SG Americas Securities LLC87,987$1.34M0.0%-11.1%0.245% 11/15/2022TCG Crossover Management LLC2,104,875$21.12M6.3%N/A5.865% 11/15/2022Parkman Healthcare Partners LLC127,458$1.28M0.4%+385.6%0.355% 11/15/2022BVF Inc. IL1,508,416$14.89M0.6%+126.3%4.203% 11/15/2022Cantor Fitzgerald L. P.209,886$2.11M0.0%-0.7%0.585% 11/14/2022Point72 Asset Management L.P.550,875$5.53M0.0%+120.4%1.535% 11/14/2022UBS Oconnor LLC79,636$786K0.0%+176.4%0.222% 10/31/2022 SG Americas Securities LLC98,953$977K0.0%-2.5%0.276% 5/23/2022Cantor Fitzgerald L. P.173,725$3.30M0.2%-31.7%0.580% 5/16/2022Lombard Odier Asset Management Europe Ltd1,561,551$29.67M1.1%N/A5.218% 5/16/2022Frazier Life Sciences Management L.P.881,173$16.74M1.4%N/A2.944% 2/18/2022Lombard Odier Asset Management USA Corp3,472,521$82.96M3.2%+480.6%11.603% 2/15/2022Consonance Capital Management LP758,253$18.12M11.8%+324.1%2.534% 2/15/2022Adage Capital Partners GP L.L.C.550,000$13.14M0.0%+23.8%1.838% 2/14/2022Lombard Odier Asset Management USA Corp2,134,750$40.95M1.6%+256.9%7.133% 2/14/2022Point72 Asset Management L.P.250,000$5.97M0.0%N/A0.835% 2/14/2022Deep Track Capital LP950,798$22.72M1.6%N/A3.177% 2/14/2022Blair William & Co. IL56,026$1.34M0.0%+26.1%0.187% 2/10/2022Citigroup Inc.58,333$1.37M0.0%N/A0.195% 2/10/2022Bellevue Group AG46,666$1.09M0.0%N/A0.156% 2/8/2022Frazier Management LLC886,173$21.17M1.6%N/A2.961% 2/7/2022 SG Americas Securities LLC101,845$2.38M0.0%+701.8%0.340% 11/15/2021Lombard Odier Asset Management USA Corp598,141$10.65M0.5%-34.5%1.999% 11/1/2021 SG Americas Securities LLC12,702$275K0.0%+135.1%0.042% 8/13/2021Lombard Odier Asset Management USA Corp913,134$21.61M0.9%-23.8%3.054% 5/18/2021BVF Inc. IL666,666$15.82M0.6%N/A2.238% The #1 Crypto for AI (Ad)We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW.5/18/2021Lombard Odier Asset Management USA Corp1,198,141$24.43M0.9%+121.9%4.021% 5/13/2021 SG Americas Securities LLC5,445$129K0.0%N/A0.020% 11/16/2020Lombard Odier Asset Management USA Corp540,000$8.10M0.5%N/A1.956% (Data available from 1/1/2016 forward) SLN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SLN shares? During the previous two years, 14 institutional investors and hedge funds held shares of Silence Therapeutics. The most heavily invested institutionals were Vivo Capital LLC ($23.88M), TCG Crossover Management LLC ($21.12M), Lombard Odier Asset Management Europe Ltd ($18.78M), Lombard Odier Asset Management USA Corp ($18.67M), Frazier Life Sciences Management L.P. ($16.74M), BVF Inc. IL ($14.89M), and Artal Group S.A. ($9.35M).Learn more on SLN's institutional investors. What percentage of Silence Therapeutics stock is owned by institutional investors? 98.73% of Silence Therapeutics stock is owned by institutional investors. Learn more on SLN's institutional investor holdings. Which institutional investors have been buying Silence Therapeutics stock? Of the 14 institutional investors that purchased Silence Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: TCG Crossover Management LLC ($2.10M), Lombard Odier Asset Management Europe Ltd ($1.68M), Artal Group S.A. ($1.19M), Vivo Capital LLC ($1.11M), Frazier Life Sciences Management L.P. ($881.17K), BVF Inc. IL ($841.75K), and M28 Capital Management LP ($363.80K). How much institutional buying is happening at Silence Therapeutics? Institutional investors have bought a total of 9,077,287 shares in the last 24 months. This purchase volume represents approximately $116.94M in transactions. Which Silence Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Silence Therapeutics stock in the last 24 months: Cantor Fitzgerald L. P. ($103.78K), SG Americas Securities LLC ($13.47K), and Lombard Odier Asset Management Europe Ltd ($1.20K). How much institutional selling is happening at Silence Therapeutics? Institutional investors have sold a total of 118,450 shares in the last 24 months. This volume of shares sold represents approximately $2.13M in transactions. Related Companies: CVAC Major Shareholders PAHC Major Shareholders ORIC Major Shareholders LYEL Major Shareholders PHAR Major Shareholders ZYME Major Shareholders BCYC Major Shareholders NUVB Major Shareholders NRIX Major Shareholders OLMA Major Shareholders This page (NASDAQ:SLN) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 Media348 million Americans lives to END as we know it?The Oxford ClubThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silence Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.